Edward Dulac is the founder of Fate Therapeutics. Fate Therapeutics has raised $57M in total funding. Latest round: Series B.
Edward Dulac was appointed as Chief Financial Officer for Fate Therapeutics in August 2020. Prior to joining Fate Therapeutics, he served as Vice President, Business Development & Strategy at Celgene Corporation for over 20 years, contributing to finance, business development, and product portfolio strategy. He holds a B.S. in Pharmacy from the University of Pittsburgh and an M.B.A. from the Kelley School of Business at Indiana University.
Full founder directory · Investor directory · Company funding database · Fundraising library